BRPI0000967B8 - processos para preparação de compostos secretagogos de hormônio de crescimento - Google Patents

processos para preparação de compostos secretagogos de hormônio de crescimento

Info

Publication number
BRPI0000967B8
BRPI0000967B8 BRPI0000967A BRPI0000967A BRPI0000967B8 BR PI0000967 B8 BRPI0000967 B8 BR PI0000967B8 BR PI0000967 A BRPI0000967 A BR PI0000967A BR PI0000967 A BRPI0000967 A BR PI0000967A BR PI0000967 B8 BRPI0000967 B8 BR PI0000967B8
Authority
BR
Brazil
Prior art keywords
growth hormone
processes
hormone secretagogue
compounds
preparing growth
Prior art date
Application number
BRPI0000967A
Other languages
English (en)
Inventor
Kwok-Fung Chiu Charles
Nathaniel Meltz Clifford
Robert Busch Frank
Robert Rose Peter
James Post Ronald
Original Assignee
Pfizer Prod Inc
Raqualia Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc, Raqualia Pharma Inc filed Critical Pfizer Prod Inc
Priority to BRPI0017522A priority Critical patent/BRPI0017522B8/pt
Publication of BRPI0000967A publication Critical patent/BRPI0000967A/pt
Publication of BRPI0000967B1 publication Critical patent/BRPI0000967B1/pt
Publication of BRPI0000967B8 publication Critical patent/BRPI0000967B8/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0202—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the structure -NH-X-X-C(=0)-, X being an optionally substituted carbon atom or a heteroatom, e.g. beta-amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06191—Dipeptides containing heteroatoms different from O, S, or N
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pyridine Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

patente de invenção: <b>"processo para preparação de secretagogos de hormônio de crescimento"<d>. esta invenção refere-se a processos melhorados de preparação de compostos da fórmula ii, e compostos da fórmula iii, em que r¹, r² r³ e prt são definidos como descrito nas especificações.
BRPI0000967A 1999-02-26 2000-02-28 processos para preparação de compostos secretagogos de hormônio de crescimento BRPI0000967B8 (pt)

Priority Applications (1)

Application Number Priority Date Filing Date Title
BRPI0017522A BRPI0017522B8 (pt) 1999-02-26 2000-02-28 processo para preparação de secretagogos de hormônio de crescimento e polimorfo

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US12274599P 1999-02-26 1999-02-26

Publications (3)

Publication Number Publication Date
BRPI0000967A BRPI0000967A (pt) 2001-09-11
BRPI0000967B1 BRPI0000967B1 (pt) 2012-06-12
BRPI0000967B8 true BRPI0000967B8 (pt) 2021-12-07

Family

ID=22404505

Family Applications (2)

Application Number Title Priority Date Filing Date
BRPI0000967A BRPI0000967B8 (pt) 1999-02-26 2000-02-28 processos para preparação de compostos secretagogos de hormônio de crescimento
BRPI0017522A BRPI0017522B8 (pt) 1999-02-26 2000-02-28 processo para preparação de secretagogos de hormônio de crescimento e polimorfo

Family Applications After (1)

Application Number Title Priority Date Filing Date
BRPI0017522A BRPI0017522B8 (pt) 1999-02-26 2000-02-28 processo para preparação de secretagogos de hormônio de crescimento e polimorfo

Country Status (44)

Country Link
US (2) US6541634B2 (pt)
EP (2) EP1031575B1 (pt)
JP (3) JP3437813B2 (pt)
KR (2) KR100372063B1 (pt)
CN (3) CN1137891C (pt)
AP (1) AP1221A (pt)
AR (2) AR029617A1 (pt)
AT (1) ATE277944T1 (pt)
AU (1) AU764122B2 (pt)
BG (1) BG104175A (pt)
BR (2) BRPI0000967B8 (pt)
CA (1) CA2299495C (pt)
CO (1) CO5160252A1 (pt)
DE (1) DE60014212T2 (pt)
DK (1) DK1031575T3 (pt)
DZ (1) DZ3018A1 (pt)
EA (1) EA003218B1 (pt)
EE (1) EE200000193A (pt)
ES (1) ES2226712T3 (pt)
GT (1) GT200000018A (pt)
HK (1) HK1030219A1 (pt)
HN (1) HN2000000021A (pt)
HR (1) HRP20000103A2 (pt)
HU (1) HUP0000907A3 (pt)
ID (1) ID24861A (pt)
IL (2) IL157103A (pt)
IN (1) IN192352B (pt)
IS (1) IS5380A (pt)
MA (1) MA25072A1 (pt)
NO (1) NO20000965L (pt)
NZ (1) NZ503062A (pt)
OA (1) OA11325A (pt)
PA (1) PA8491201A1 (pt)
PE (1) PE20001550A1 (pt)
PL (1) PL338628A1 (pt)
PT (1) PT1031575E (pt)
SG (1) SG90096A1 (pt)
SI (1) SI1031575T1 (pt)
SK (1) SK284982B6 (pt)
TN (1) TNSN00035A1 (pt)
TR (1) TR200000536A2 (pt)
TW (2) TW200718702A (pt)
UA (1) UA70306C2 (pt)
ZA (1) ZA200000888B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1132388A3 (en) * 2000-03-09 2004-03-03 Pfizer Products Inc. Hexahydropyrazolo[4,3-c]pyridine metabolites
EP1289526A4 (en) 2000-05-30 2005-03-16 Merck & Co Inc MELANOCORTIN RECEPTOR AGONISTS
WO2004103983A1 (en) * 2003-05-26 2004-12-02 Biocon Limited Process for the preparation of s(+)-2-ethoxy-4-[n-{1-(2-piperidinophelyl)-3-methyl-1- butyl} aminocarbonylmethyl]benzoic acid derivatives
WO2005027913A1 (en) * 2003-09-19 2005-03-31 Pfizer Products Inc. Pharmaceutical compositions and methods comprising combinations of 2-alkylidene-19-nor-vitamin d derivatives and a growth hormone secretagogue
US9117477B2 (en) 2013-05-08 2015-08-25 HGST Netherlands B.V. Perpendicular magnetic recording media having novel seed layer
MX360906B (es) * 2013-05-28 2018-11-21 Raqualia Pharma Inc Forma cristalina del l-tartrato de 2-amino-n[2-(3a-(r)- bencil-2-metil-3-oxo-2,3,3a,4,6,7-hexahidro-pirazolo[4,3-c]piridi n-5-il)-1-(r)-benciloximetil-2-oxo-etil]-isobutiramida.
CN109320515A (zh) * 2018-11-22 2019-02-12 常州大学 一种Capromorelin手性中间体的不对称合成方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8610980D0 (en) 1986-05-06 1986-06-11 Ici America Inc Heterocyclic fused tricyclic compounds
GB8901423D0 (en) 1989-01-23 1989-03-15 Fujisawa Pharmaceutical Co Pyrazolopyridine compound and processes for preparation thereof
US5578593A (en) 1992-12-11 1996-11-26 Merck & Co., Inc. Spiro piperidines and homologs promote release of growth hormone
EP0739204A4 (en) 1993-11-09 2000-03-15 Merck & Co Inc PIPERIDINE, PYRROLIDINE AND HEXAHYDRO-1H-AZEPINE SUPPORT THE RELEASE OF THE GROWTH HORMONE
US5609150A (en) 1995-04-18 1997-03-11 Maged; Jeffrey M. Method for dilating respiratory passages
TW432073B (en) 1995-12-28 2001-05-01 Pfizer Pyrazolopyridine compounds
AU2334097A (en) 1996-03-21 1997-10-10 Merck & Co., Inc. 4-spiroindoline piperidines promote release of growth hormone
WO1997036873A1 (en) 1996-04-03 1997-10-09 Merck & Co., Inc. Piperidines, pyrrolidines and hexahydro-1h-azepines promote release of growth hormone
UA64751C2 (uk) * 1997-06-25 2004-03-15 Пфайзер Продактс Інк. Спосіб лікування інсулінової толерантності речовинами, які посилюють секрецію гормону росту (варіанти) та фармацевтична композиція (варіанти)
JP3514774B2 (ja) 1997-06-25 2004-03-31 ファイザー・インク 成長ホルモン分泌促進薬としてのジペプチド誘導体
UA53716C2 (uk) 1997-06-25 2003-02-17 Пфайзер Продактс Інк. Тартратна сіль заміщеного дипептиду, спосіб її одержання, проміжні сполуки та спосіб їх одержання, фармацевтична композиція (варіанти), спосіб підвищення рівнів ендогенного гормону росту та спосіб лікування або профілактики захворювань (варіанти)

Also Published As

Publication number Publication date
HUP0000907A2 (en) 2001-03-28
EA200000172A2 (ru) 2000-08-28
JP2003261565A (ja) 2003-09-19
PL338628A1 (en) 2000-08-28
IL157103A (en) 2007-07-24
EE200000193A (et) 2000-10-16
EP1031575B1 (en) 2004-09-29
PA8491201A1 (es) 2001-04-30
ZA200000888B (en) 2001-08-23
IL134599A (en) 2006-12-10
UA70306C2 (en) 2004-10-15
JP4051314B2 (ja) 2008-02-20
AP1221A (en) 2003-11-03
ES2226712T3 (es) 2005-04-01
HUP0000907A3 (en) 2001-05-28
AR053722A2 (es) 2007-05-16
ID24861A (id) 2000-08-31
IS5380A (is) 2000-08-27
SK284982B6 (sk) 2006-03-02
GT200000018A (es) 2001-08-16
BRPI0017522A2 (pt) 2009-12-22
KR20020065455A (ko) 2002-08-13
BRPI0000967A (pt) 2001-09-11
JP3437813B2 (ja) 2003-08-18
TW200718702A (en) 2007-05-16
BRPI0000967B1 (pt) 2012-06-12
IN192352B (pt) 2004-04-10
CN1270960A (zh) 2000-10-25
NO20000965L (no) 2000-08-28
NO20000965D0 (no) 2000-02-25
ATE277944T1 (de) 2004-10-15
US6541634B2 (en) 2003-04-01
IL157103A0 (en) 2004-02-08
EP1031575A1 (en) 2000-08-30
SG90096A1 (en) 2002-07-23
CN1137891C (zh) 2004-02-11
EP1449842A1 (en) 2004-08-25
AR029617A1 (es) 2003-07-10
HK1030219A1 (en) 2001-04-27
KR100361783B1 (ko) 2002-11-22
IL134599A0 (en) 2001-04-30
PE20001550A1 (es) 2001-01-11
CO5160252A1 (es) 2002-05-30
EA200000172A3 (ru) 2000-10-30
US20020002283A1 (en) 2002-01-03
MA25072A1 (fr) 2000-10-01
SK2302000A3 (en) 2000-11-07
HU0000907D0 (en) 2000-04-28
TWI286142B (en) 2007-09-01
AP2000001754A0 (en) 2000-03-31
KR100372063B1 (ko) 2003-02-14
HN2000000021A (es) 2001-02-02
KR20010006698A (ko) 2001-01-26
US20030158414A1 (en) 2003-08-21
US6673929B2 (en) 2004-01-06
NZ503062A (en) 2001-07-27
BRPI0017522B8 (pt) 2021-05-25
CA2299495C (en) 2010-06-15
DE60014212D1 (de) 2004-11-04
SI1031575T1 (en) 2005-02-28
EA003218B1 (ru) 2003-02-27
AU764122B2 (en) 2003-08-07
TR200000536A2 (tr) 2000-09-21
CN1515570A (zh) 2004-07-28
AU1947100A (en) 2000-08-31
PT1031575E (pt) 2004-11-30
OA11325A (en) 2003-10-27
HRP20000103A2 (en) 2001-04-30
DE60014212T2 (de) 2005-12-15
DZ3018A1 (fr) 2004-03-20
JP2003327585A (ja) 2003-11-19
TNSN00035A1 (fr) 2005-11-10
CA2299495A1 (en) 2000-08-26
JP2000247974A (ja) 2000-09-12
BRPI0017522B1 (pt) 2013-09-24
CN1837205A (zh) 2006-09-27
DK1031575T3 (da) 2005-01-03
BG104175A (bg) 2000-12-29

Similar Documents

Publication Publication Date Title
SE0002102D0 (sv) Chemical compound
BR9813740A (pt) Teriparatìdeo cristalino
BR9913512A (pt) Derivados de 4,4-biarilpiperidina com atividade de receptor de opióide
BR0009480A (pt) Soluções de poliuretano com unidades de estrutura de alcoxissilano
BR9811677A (pt) Resinas de polialcanolamida adesivas para adesivos enrugados
ATE327257T1 (de) Fester, stabiler und konzentrierter biologisch verdaulicher komplex von orthokieselsäure und prozess zur dessen herstellung
BR0100982A (pt) Processo para a preparação de derivados deresorcinol
BR9909739A (pt) Benzotiadiazóis e derivados
BRPI0000967B8 (pt) processos para preparação de compostos secretagogos de hormônio de crescimento
BR9905732A (pt) Processo e intermediários para secretagogos do hormÈnio do crescimento
BR9811855A (pt) Processo para preparação de ácido l-ascórbico
BRPI0108990B8 (pt) processo para preparação de derivados de pirimidona com atividade antifungos
BR9807988A (pt) Processo para a preparação de um composto, e, composto.
BR9909898A (pt) Processo para purificação de um derivado de cefalosporina
BR0011996A (pt) Preparação de piperidin-4-onas substituìdas
PT1303267E (pt) Sistema de aplicacao dermico para o acido aminolevulinico
BR0016638B1 (pt) compostos anÁlogos de homopiperidilbenzimidazàis substituÍdos como relaxantes féndicos, processo para preparar os mesmos, composiÇço farmacÊutica e processo para preparÁ-la.
BR0013751A (pt) Processo para produção de derivados de ácido naftiridina-3-carboxìlico
BR0009453A (pt) Processo para a preparação de um composto
PT1228026E (pt) Compostos relacionados com o acido 15-hidroxieicosatetraenoico
BRPI9807312B8 (pt) derivados de (4-piperidinil)-1h-2-benzopirano úteis como agentes antipsicóticos, composição farmacêutica e processo para a preparação dos referidos derivados
IT1303759B1 (it) Procedimento migliorato per la preparazione di acido 7-azaindolil-3-carbossilico.
BR0000901A (pt) Derivados 4-fenil-4-heteroarilpiperidina
IL138638A0 (en) Processes for preparing intermediates
BR0116853A (pt) Processo para a preparação de um composto, e, composto.

Legal Events

Date Code Title Description
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 12/06/2012, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]
B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/02/00, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: REF. RPI 2162 DE 12/06/2012 QUANTO AO PRAZO DE VALIDADE DE 20 (VINTE) ANOS CONTADOS A PARTIR DE 28/02/2000, OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF, QUE DETERMINA A ALTERACAO DO PRAZO DE CONCESSAO.

B21A Patent or certificate of addition expired [chapter 21.1 patent gazette]

Free format text: PATENTE EXTINTA EM 28.02.2020